Qipeng Yan

Qipeng Yan

Auto-generated profile, based on publicly available information

Qipeng Yan

Hunan Provincial Key Laboratory of Animal Models and Molecular Medicine, State Key Laboratory of Chemo/bio-Sensing and Chemometrics, School of Biomedical Science

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 April 2025 in Cell Discovery
Verified
Journal Article
Open access
PDF file
SLSanling Liu
Sanling Liu
YZYining Zheng
Yining Zheng
HCHaopeng Chen
Haopeng Chen
XLXin Li
Xin Li
QYQipeng Yan
Qipeng Yan
CTChanglin Tian
Changlin Tian
The α7 nicotinic acetylcholine receptor (nAChR), a pentameric ligand-gated ion channel, plays important roles in cognition, neuroprotection, and anti-inflammation. As a potential drug target, α7 nAChR has different binding sites for different ligands, particularly agonists and positive allosteric modulators (PAMs). Ago-PAMs can both directly activate and allosterically modulate α7 nAChR. However, the mechanism underlying α7 nAChR modulation by ago-PAM has yet to be fully elucidated. Here, we present cryo-EM structures of α7 nAChR in complex with the ago-PAM GAT107 and Ca2+ in the open and desensitized states, respectively. Our results from both structural comparisons and functional assays suggest an allosteric mechanism underlying GAT107 modulation and calcium potentiation of α7 nAChR, involving local conformational changes in the ECD–TMD coupling region and a global structural rearrangement in the transmembrane domain. This work provides a new mechanism of α7 nAChR gating distinct from that of conventional agonist binding. These findings would aid in drug design and enrich our biophysical understanding of pentameric ligand-gated ion channels.

26 July 2025 in Journal of Chemical Information and Modeling
Verified
Journal Article
Closed access
MLMin Lu
Min Lu
LDLei Du
Lei Du
ZCZiwei Cui
Ziwei Cui
YZYiming Zhao
Yiming Zhao
QYQipeng Yan
Qipeng Yan
GGGuo-Ping Guo
Guo-Ping Guo

1 July 2025 in Biomacromolecules
Verified
Journal Article
Closed access
QYQipeng Yan
Qipeng Yan
XJXingyue Jiang
Xingyue Jiang
WXWei Xie
Wei Xie
XWXia Wu
Xia Wu
DGDalian Gong
Dalian Gong
Junfeng ShiJunfeng Shi
Junfeng Shi

30 April 2026 in Nature Communications
Verified
Journal Article
Open access
CWCui-Zhen Wang
Cui-Zhen Wang
HHHuisi Huang
Huisi Huang
ZHZhihui Hu
Zhihui Hu
LGLongwei Gao
Longwei Gao
ZLZhi-Qiao Lin
Zhi-Qiao Lin
JWJian-Bo Wang
Jian-Bo Wang
Gate residues, acting in concert with distal dynamic networks, are emerging as critical yet underexploited regulators of enzymatic catalysis. Here we show that conformational dynamics analysis of fluoroacetate dehalogenase RPA1163 reveals a gate-based allosteric pair (K181-W185) that governs substrate access and reactivity. Network engineering of this pair yields a double mutant with high turnover number for α-fluorophenylpropionic acid (turnover number > 2 × 10⁵), establishing gate-centric allostery as a generalizable design principle. Structural and molecular dynamics analyses show that the activity enhancement arises from stabilization of catalytically competent open states through long-range coupling. Extension of this strategy to three additional dehalogenases confirms the universality of gate-based dynamic rewiring. Leveraging this framework, we establish a robust biocatalytic platform for stereoselective synthesis of α-fluoro and α-hydroxy carboxylic acids, achieving high productivity (turnover number > 3.7 × 10⁶) and enabling decagram-scale preparation of pharmaceutically relevant intermediates with high yield and enantioselectivity. Together, these findings establish gate-residue allostery as a powerful concept in protein engineering, bridging conformational dynamics with translational biocatalysis.

1 December 2025 in Green Synthesis and Catalysis
Verified
Journal Article
Open access
MLMin Li
Min Li
QYQipeng Yan
Qipeng Yan
YWYueming Wang
Yueming Wang
RQRuiying Qiu
Ruiying Qiu
LGLongwei Gao
Longwei Gao
JWJian-Bo Wang
Jian-Bo Wang

16 May 2026 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
JWJiaying Wei
Jiaying Wei
QYQipeng Yan
Qipeng Yan
XJXingyue Jiang
Xingyue Jiang
WXWei Xie
Wei Xie
MWMin Wei
Min Wei
Junfeng ShiJunfeng Shi
Junfeng Shi